Karol M. Cordoba

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates.

Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates.

Journal: Gut

Published: April 09, 2024

Exploring current and emerging therapies for porphyrias.

Exploring current and emerging therapies for porphyrias.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 29, 2024

Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria.

Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria.

Journal: International journal of molecular sciences

Published: June 29, 2023

The Alpha-Lipoic Acid Improves Glucose Metabolism and Hyperinsulinemia in Acute Intermittent Porphyria: A Nutritional Concept for the Management of Rare Disorders.

The Alpha-Lipoic Acid Improves Glucose Metabolism and Hyperinsulinemia in Acute Intermittent Porphyria: A Nutritional Concept for the Management of Rare Disorders.

Journal: Cellular and molecular gastroenterology and hepatology

Published: June 19, 2023

Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria.

Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria.

Journal: International journal of molecular sciences

Published: November 15, 2022

Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment.

Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment.

Journal: Life (Basel, Switzerland)

Published: October 20, 2022

Messenger RNA as a personalized therapy: The moment of truth for rare metabolic diseases.

Messenger RNA as a personalized therapy: The moment of truth for rare metabolic diseases.

Journal: International review of cell and molecular biology

Published: September 05, 2022

Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria.

Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria.

Journal: Science translational medicine

Published: January 12, 2022

Diagnosis and Management of Inborn Errors of Metabolism in Adult Patients in the Emergency Department.

Diagnosis and Management of Inborn Errors of Metabolism in Adult Patients in the Emergency Department.

Journal: Diagnostics (Basel, Switzerland)

Published: October 30, 2021

Mechanistic modelling of enzyme-restoration effects of new recombinant liver-targeted proteins in acute intermittent porphyria.

Mechanistic modelling of enzyme-restoration effects of new recombinant liver-targeted proteins in acute intermittent porphyria.

Journal: British journal of pharmacology

Published: October 25, 2021

High Prevalence of Insulin Resistance in Asymptomatic Patients with Acute Intermittent Porphyria and Liver-Targeted Insulin as a Novel Therapeutic Approach.

High Prevalence of Insulin Resistance in Asymptomatic Patients with Acute Intermittent Porphyria and Liver-Targeted Insulin as a Novel Therapeutic Approach.

Journal: Biomedicines

Published: January 19, 2021

mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks.

mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks.

Journal: Molecular therapy. Nucleic acids

Published: December 12, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026